Stuart Therapeutics Unveils Phase III Results for Novel Dry Eye Candidate
ST-100 missed its primary endpoint—but showed visible healing on the eye’s surface by Day 4. Stuart Therapeutics (Florida, United States)…
WSPOS Myopia Consensus Statement 2025: What Parents and Practitioners Need to Know
Myopia, or nearsightedness, has become one of the most pressing pediatric health issues of our time. What used to be…
latest posts
